Arden enters professional skin care market

Elizabeth Arden, Inc. has unveiled Triple Protection Factor Broad Spectrum Sunscreen SPF 50+, or TPF 50, which the beauty company is billing as a “groundbreaking new anti-aging product.” The launch marks the roll-out of a comprehensive new skincare line called Elizabeth Arden Rx, designed for exclusive distribution in physician offices.

A key pillar to Elizabeth Arden's omni-channel growth strategy, Elizabeth Arden Rx marks the company's official entry into the global professional skincare market.

TPF 50 was developed based on a unique combination of protective and restorative ingredients including a DNA Enzyme Complex, a highly potent protein protection antioxidant complex and broad spectrum SPF 50+ sun protection. This combination works synergistically to create the most effective topical skin protection on the market, according to Arden.
 
Elizabeth Arden is rolling out the line  in tandem with today’s release of a clinical study published in the Journal of Drugs in Dermatology. The results of the double-blind irradiation study show TPF 50 to be significantly more effective than other topical products with DNA enzymes, antioxidants and/or growth factors when these products were used in combination with SPF 50 sunscreens.

The Elizabeth Arden Rx line will debut at the annual American Academy of Dermatology Meeting  later this month. The products will be available exclusively at physician offices beginning in April 2014.

Zoom Lebron XIV 14